Benign recurrent intrahepatic cholestasis: treatment with S-adenosylmethionine

Gastroenterology. 1989 May;96(5 Pt 1):1354-7. doi: 10.1016/s0016-5085(89)80024-1.

Abstract

S-Adenosylmethionine (800 mg i.v. per day) was used to treat two brothers and a brother and sister from each of two kindreds with benign recurrent intrahepatic cholestasis. Symptoms, routine tests of liver function, concentrations of total bile acids, and the oral clearances of [11,12-2H]chenodeoxycholic acid and [24-13C]cholic acid were determined before and after treatment with S-adenosylmethionine. S-Adenosylmethionine did not ameliorate symptoms or biochemical parameters of cholestasis but reduced bile acid clearances in 3 of 4 subjects. Transaminase levels in both subjects of one kindred rose during treatment. These limited, preliminary observations suggest that S-adenosylmethionine may be ineffective in the therapy of benign recurrent intrahepatic cholestasis and may be hepatotoxic in some patients.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Bile Acids and Salts / metabolism
  • Bilirubin / metabolism
  • Cholestasis, Intrahepatic / drug therapy*
  • Cholestasis, Intrahepatic / genetics
  • Cholestasis, Intrahepatic / metabolism
  • Female
  • Humans
  • Liver / enzymology
  • Liver / metabolism
  • Liver Function Tests
  • Male
  • Recurrence
  • S-Adenosylmethionine / therapeutic use*

Substances

  • Bile Acids and Salts
  • S-Adenosylmethionine
  • Bilirubin